Optimized reference region and the effect on test-retest reliability and sensitivity to differences between Parkinson’s disease and control groups with [ <sup>11</sup> C]UCB-J
0.61 for SN and 0.66 for caudate) compared to CS2mL (0.38 for SN and 0.43 for caudate).
Authors
- Nabeel Nabulsi (ORCID: https://orcid.org/0000-0001-8129-0051)
- Mahsa Mayeli (ORCID: https://orcid.org/0000-0003-4656-156X)
- Richard E. Carson (ORCID: https://orcid.org/0000-0002-9338-7966)
- Faranak Ebrahimian Sadabad (ORCID: https://orcid.org/0000-0002-6649-7211)
- Takuya Toyonaga (ORCID: https://orcid.org/0000-0002-0369-8294)
- Sophie Holmes (ORCID: https://orcid.org/0000-0002-4929-1932)
- Nikkita Khattar (ORCID: https://orcid.org/0000-0003-3484-2452)
- Mika Naganawa (ORCID: https://orcid.org/0000-0002-4408-2621)
- Irina Esterlis (ORCID: https://orcid.org/0000-0001-6293-1458)
- Sjoerd J. Finnema (ORCID: https://orcid.org/0000-0002-4972-3627)
- Christopher H. van Dyck (ORCID: https://orcid.org/0000-0003-1779-097X)
- Deepak Cyril D’Souza (ORCID: https://orcid.org/0000-0003-3141-1462)
- Adam P. Mecca (ORCID: https://orcid.org/0000-0003-1982-5443)
- David Matuskey (ORCID: https://orcid.org/0000-0001-7508-6572)
- Jean-Dominique Gallezot
Institutions
- AbbVie (United States) (US)
- Yale University (US)
Publication Details
- Journal
- Journal of Cerebral Blood Flow & Metabolism
- Published
- 2026-04-10
- DOI
- https://doi.org/10.1177/0271678x261441071
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Yale University
- AbbVie
- National Institutes of Health
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke